ANN ARBOR, Mich., July 01, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it has appointed Craig Thompson, Chief Executive Officer of Cerevance, to its Board of Directors. Mr.

Following Bayer's acquisition of Schering in 2006, Sebastian served as Chief Executive Officer of Bayer Turk, Istanbul, and was Senior Representative of the Bayer Group in Turkey.

His experience extends way beyond there, though; Guth has been with Bayer’s pharma business before it was Bayer’s pharma business. He joined Schering AG as a project lead in Asia and the ...

As a member of the Board of Management and Labor Director of Bayer Schering Pharma AG, Berlin, Germany, from 2006 through September 2009, his roles included actively participating in this company ...

BERLIN – German pharmaceutical and chemical company Bayer AG said Thursday it would make a $19.5 billion white-knight offer for Schering AG, bidding against a hostile takeover effort from Merck KgA.

At least 18 studies based on the IMPROVE HF data have been reported to date. The latest focused on changes in LVEF from baseline to 24 months among patients in IMPROVE HF who survived and had ...

Medscape interviewed Mihai Gheorghiade, MD, concerning the IMPROVE-HF study that provided support a new paradigm for how heart failure should be viewed and treated.

In Gedeon Richter plc v Bayer Schering Pharma AG [2011] EWHC 583 (Pat), Gedeon Richter plc applied to have two divisional patents belonging to Bayer Schering Pharma AG revoked for invalidity (the ...

Berlin, May 7, 2010 - Bayer Schering Pharma AG, Germany, today announced that the company has started to enroll patients in an international Phase III trial to evaluate its investigational ...

SINGAPORE -- German pharmaceutical giant Bayer Schering Pharma AG said Friday it will invest heavily in Asia by doubling its sales team in India and tripling its workforce in Vietnam and that it ...